To validate these findings functionally, we assessed the protein expression levels of HLA-A, HLA-B, and HLA-C, the non-classical MHC-I (HLA-E), as well as IFITM1 and IFITM2 in T cells derived from both healthy skin and MF skin lesions using Western blot analysis. The gene discussed is HLA-C; the disease is mycosis fungoides.